Literature DB >> 15615157

Lessons learned from the WHI: HRT requires a cautious and individualized approach.

Mira Aubuchon1, Nanette Santoro.   

Abstract

The Women's Health Initiative (WHI) was a randomized, double-blinded, placebo-controlled study that evaluated the benefits and risks of hormone replacement therapy (HRT) for healthy postmenopausal women. The results indicated that HRT: 1) does not confer cardiovascular or cognitive protection; 2) increases breast cancer risk in women with a uterus; 3) increases stroke risk in women with hysterectomy; and 4) does not improve overall quality of life. HRT does, however, decrease fracture rates and vasomotor symptoms. Because the results were surprising in light of prior observational and animal research, the study generated enormous controversy as to how to use HRT. Our position is that long-term HRT is not appropriate for most postmenopausal women, but treatment should be individualized for each patient.

Entities:  

Mesh:

Year:  2004        PMID: 15615157

Source DB:  PubMed          Journal:  Geriatrics        ISSN: 0016-867X


  3 in total

Review 1.  Aromatase, breast cancer and obesity: a complex interaction.

Authors:  Serdar E Bulun; Dong Chen; Irene Moy; David C Brooks; Hong Zhao
Journal:  Trends Endocrinol Metab       Date:  2011-12-12       Impact factor: 12.015

2.  Understanding estrogen action during menopause.

Authors:  Jameel Iqbal; Mone Zaidi
Journal:  Endocrinology       Date:  2009-08       Impact factor: 4.736

Review 3.  Genetics of primary ovarian insufficiency: a review.

Authors:  Cristina Fortuño; Elena Labarta
Journal:  J Assist Reprod Genet       Date:  2014-09-18       Impact factor: 3.412

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.